Literature DB >> 6656871

Instability of the Trypanosoma brucei rhodesiense metacyclic variable antigen repertoire.

J D Barry, J S Crowe, K Vickerman.   

Abstract

Trypanosoma brucei rhodesiense undergoes antigenic variation in its mammalian host by changing the glycoprotein composing its surface coat. Trypanosome clones which have the same repertoire of variable antigen types (VATs) are said to belong to the same serodeme. Tsetse flies infected with a particular serodeme extrude infective metacyclic trypanosomes which express only a restricted part of this repertoire. As the only known acquired immunity in African trypanosomiasis is VAT-specific this limitation of metacyclic VAT (M-VAT) repertoire could be important in devising a vaccine. This possibility of immunoprophylaxis could depend, however, on whether or not the M-VAT repertoire is conserved over long periods of repeated cyclical transmission and between epidemics. Studies reported here on isolates made from an East African focus of sleeping sickness over a 20-yr period suggest substantial changes in the M-VATs expressed during this time. Furthermore, we have detected change in expression of 3 M-VATs during sequential tsetse transmission of a clone in the laboratory indicating a possible instability in the organization of M-VAT genes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6656871     DOI: 10.1038/306699a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  18 in total

1.  Ex vivo and in vitro identification of a consensus promoter for VSG genes expressed by metacyclic-stage trypanosomes in the tsetse fly.

Authors:  Michael L Ginger; Patricia A Blundell; Alyson M Lewis; Alison Browitt; Arthur Günzl; J David Barry
Journal:  Eukaryot Cell       Date:  2002-12

Review 2.  Molecular biology of trypanosome antigenic variation.

Authors:  J E Donelson; A C Rice-Ficht
Journal:  Microbiol Rev       Date:  1985-06

3.  Predominance of duplicative VSG gene conversion in antigenic variation in African trypanosomes.

Authors:  N P Robinson; N Burman; S E Melville; J D Barry
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Duplicative activation mechanisms of two trypanosome telomeric VSG genes with structurally simple 5' flanks.

Authors:  K R Matthews; P G Shiels; S V Graham; C Cowan; J D Barry
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

5.  A flagellar pocket membrane fraction from Trypanosoma brucei rhodesiense: immunogold localization and nonvariant immunoprotection.

Authors:  J G Olenick; R Wolff; R K Nauman; J McLaughlin
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

6.  Metacyclic variant surface glycoprotein genes of Trypanosoma brucei subsp. rhodesiense are activated in situ, and their expression is transcriptionally regulated.

Authors:  M J Lenardo; K M Esser; A M Moon; L H Van der Ploeg; J E Donelson
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

7.  Synchronous expression of individual metacyclic variant surface glycoprotein genes in Trypanosoma brucei.

Authors:  Kiantra Ramey-Butler; Elisabetta Ullu; Nikolay G Kolev; Christian Tschudi
Journal:  Mol Biochem Parasitol       Date:  2015-04-18       Impact factor: 1.759

8.  Characteristics of trypanosome variant antigen genes active in the tsetse fly.

Authors:  A W Cornelissen; G A Bakkeren; J D Barry; P A Michels; P Borst
Journal:  Nucleic Acids Res       Date:  1985-07-11       Impact factor: 16.971

9.  Characterization of the genes specifying two metacyclic variable antigen types in Trypanosoma brucei rhodesiense.

Authors:  M J Lenardo; A C Rice-Ficht; G Kelly; K M Esser; J E Donelson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

10.  African trypanosome infections in mice that lack the interferon-gamma receptor gene: nitric oxide-dependent and -independent suppression of T-cell proliferative responses and the development of anaemia.

Authors:  N A Mabbott; P S Coulson; L E Smythies; R A Wilson; J M Sternberg
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.